Lijiang Biotechnology starts construction of blood perfusion device plant

Lijiang Biotechnology held a groundbreaking ceremony for a disposable blood perfusion device project in Weixian, Hebei, China. The project has a planned investment of 200 million RMB and is expected to be completed in 2021, with an annual capacity of 1 million devices.

“The commencement and completion of this project will undoubtedly usher in a new chapter in our company's development”en.hebeilijiang.com

• 1 source
• en.hebeilijiang.comWarm congratulations on the grand opening ceremony of our company's "Disposable Blood Perfusion Device" project-Lijiang Biotechnology - Professional supplier of resin productsMar 12, 2019

Summarized from public sources; check the original articles before acting on it.